Ultrasound contrast developer Acusphere of Watertown, MA, said it is focusing the company on "partnership discussions" for its Imagify cardiac agent, and as a result is postponing plans to announce the company's new product development program.
Acusphere said it is engaged in discussions with "an extensive array of potential partners." The company believes that a partnership agreement for Imagify "would provide a strengthened financial basis both for pushing forward with our preparations for that product as well as our new product development efforts," said Sherri Oberg, president and CEO.
The company said that it had originally planned to announce its new product development program late in the third quarter, but now is focused on "more immediate priorities."
By AuntMinnie.com staff writers
September 20, 2007
Related Reading
Acusphere to raise $20 million, June 13, 2007
Acusphere reports results from Imagify phase III trials, May 4, 2007
Acusphere taps Bucceri for regulatory post, February 5, 2007
Acusphere to raise $23 million, December 7, 2006
Acusphere names Jaffe as VP, September 21, 2006
Copyright © 2007 AuntMinnie.com
